Bayubog, Julito .
HRN: 25-61-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/05/2024
08/11/2024
IV
600mg
Q6
T/C Urosepsis; Cellulitis Left Foot
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes